Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NR3C2”

107 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107 results

Early research (Phase 1)Looking for participantsNCT05807139
What this trial is testing

Spironolactone in Alcohol Use Disorder (SAUD)

Who this might be right for
Alcohol Use Disorder
National Institute on Drug Abuse (NIDA) 20
Not applicableStudy completedNCT01406015
What this trial is testing

Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications

Who this might be right for
ObesityInsulin Resistance
Brigham and Women's Hospital 38
Not applicableStudy completedNCT03174288
What this trial is testing

The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Virginia 32
Large-scale testing (Phase 3)Study completedNCT02807987
What this trial is testing

Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment

Who this might be right for
Hypertension With Moderate Renal Impairment
Daiichi Sankyo Co., Ltd. 58
Large-scale testing (Phase 3)Looking for participantsNCT06033950
What this trial is testing

Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

Who this might be right for
Heart Failure
Colorado Prevention Center 2,600
Not applicableStudy completedNCT01394627
What this trial is testing

Hypoglycemia and the Mineralocorticoid Receptor

Who this might be right for
Hypoglycemia
Brigham and Women's Hospital 21
Post-approval studies (Phase 4)Study completedNCT06381323
What this trial is testing

The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Who this might be right for
Primary AldosteronismFinerenoneMineralocorticoid Receptor Antagonist
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 55
Not applicableStudy completedNCT05526157
What this trial is testing

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 50,000
Large-scale testing (Phase 3)Study completedNCT02040441
What this trial is testing

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

Who this might be right for
Diabetic NephropathyDiabetic Retinopathy
Peter Rossing 1,777
Testing effectiveness (Phase 2)Study completedNCT02497300
What this trial is testing

Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAlbuminuria
University of Alabama at Birmingham 21
Not applicableStudy completedNCT02885662
What this trial is testing

Study of CS-3150 in Patients With Primary Aldosteronism

Who this might be right for
Primary Aldosteronism
Daiichi Sankyo Co., Ltd. 44
Not applicableStudy completedNCT03062150
What this trial is testing

Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression

Who this might be right for
Major Depression
Charite University, Berlin, Germany 232
Post-approval studies (Phase 4)Study completedNCT01837108
What this trial is testing

Eplerenone and Extracellular Adenosine Formation

Who this might be right for
Pharmacodynamics
Radboud University Medical Center 14
Testing effectiveness (Phase 2)Ended earlyNCT00647192
What this trial is testing

EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion

Who this might be right for
Atrial Fibrillation
University Hospital, Saarland 38
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Large-scale testing (Phase 3)Study completedNCT02722265
What this trial is testing

Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo Co., Ltd. 368
Not applicableEnded earlyNCT00980031
What this trial is testing

Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension

Who this might be right for
Myocardial Remodeling
Creighton University 20
Early research (Phase 1)Study completedNCT04798222
What this trial is testing

Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers

Who this might be right for
Heart Failure
AstraZeneca 20
Testing effectiveness (Phase 2)Looking for participantsNCT06906081
What this trial is testing

Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study

Who this might be right for
Cardiovascular Autonomic NeuropathyType 2 DiabetesDiabetic Neuropathies
Peter Rossing 100
Not applicableStudy completedNCT05275920
What this trial is testing

Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection Fraction
NYU Langone Health 2,211
Load More Results